Abbott LaboratoriesABT

Is ABT cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$101.95-1.41 (-1.36%)24:00 UTC
NYSEHealthcareDividend King

Company snapshot

Market Cap
$178B
Large-cap
+214%
2016 — today
10-Year Price
+167%
2016 — today
52-Week Range
$82.56$136.62
Current $101.95· 36%

Abbott Laboratories (est. 1888) is a global healthcare enterprise operating through four primary divisions. Its Established Pharmaceutical Products segment provides generic medications for conditions ranging from hypertension and dyslipidemia to gynecological and gastrointestinal disorders. The Diagnostic Products division offers laboratory systems, molecular diagnostics, point-of-care testing, and informatics. Nutritional Products delivers formulations for pediatric and adult populations. Medical Devices focuses on cardiovascular, diabetes, and neuromodulation technologies.

Similar companies

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
32.8
Below average
Below the 10-year average
Sector median 24.4above sector
P/B ratio
3.4
Historically cheap
Historically cheap relative to the last 10 years
Sector median 2.5above sector
EV / EBITDA
20.6
Around average
Around the 10-year average
Sector median 15.2above sector
Dividend Yield
2.4%
Near historic high
Near historic highs — last 10 years
Sector median 1.7%above sector
FCF Yield
4.9%
Near historic high
Near historic highs — last 10 years
Sector median -9.6%above sector
Free · No credit card needed

Get alerted when ABT is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.